Indole-positive Klebsiella pneumoniae or K. oxytoca are usually resistant to penicillins as a result of the production of a chromosomally-mediated beta-lactamase with a low level of synthesis (specific activity approximately 50 to 100 mU/mg). Although most strains are susceptible to the majority of cephalosporins, some strains exhibit resistance to cephalosporins including third-generation drugs. These resistant strains produce a chromosomally-mediated beta-lactamase with a high level of synthesis (specific activity approximately 5,000 mU/mg or higher). Four beta-lactamases have been identified on the basis of their isoelectric points: pI = 5.5, 5.7, 6.0 and 6.3; nevertheless they have similar kinetic constants, and are inhibited by clavulanic acid. These enzymes hydrolyze most third-generation cephalosporins, in the following order of decreasing velocities: cefoperazone, ceftriaxone, cefotaxime, cefodizime, cefpirome; ceftazidime, and cefoxitin, cefotetan, latamoxef, cephamycins which are totally resistant to these enzymes.

Download full-text PDF

Source

Publication Analysis

Top Keywords

chromosomally-mediated beta-lactamase
8
level synthesis
8
synthesis specific
8
specific activity
8
[klebsiella oxytoca
4
oxytoca beta-lactamases
4
beta-lactamases study
4
study action
4
action 3d-generation
4
3d-generation cephalosporins]
4

Similar Publications

Ceftolozane, a novel cephalosporin, combined with tazobactam, a known β-lactamase inhibitor, shows robust antipseudomonal activity, although it doesn't cover carbapenemases. Our review of data from 2012 to 2021 in Taiwan highlights TOL/TAZ's in-vitro performance. TOL/TAZ is most effective against (91.

View Article and Find Full Text PDF
Article Synopsis
  • Colistin is a critical last-resort antibiotic for treating multi-drug resistant Gram-negative infections, but its resistance is rising and often goes unnoticed due to inadequate testing methods.* -
  • A study in an Indian hospital analyzed 1,748 clinical samples using Vitek®2 and broth micro-dilution to detect colistin-resistant bacteria, discovering resistance primarily in Klebsiella pneumoniae and Pseudomonas aeruginosa.* -
  • The research utilized whole-genome sequencing to reveal that resistance mechanisms included specific gene deletions and mutations, with notable findings of phosphoethanolamine transferases and various mutations contributing to the resistance profile.*
View Article and Find Full Text PDF
Article Synopsis
  • - This study used bioinformatics and phenotypic tests to analyze the features of a carbapenem-resistant bacteria strain, AB073, which showed resistance to seven different classes of antibiotics due to various mechanisms like altered targets and efflux.
  • - AB073 could not transfer its antibiotic resistance through conjugation, and genetic analysis found no links to horizontal gene transfer, indicating that its resistance traits are likely innate rather than acquired.
  • - The strain also possesses genes related to virulence factors, iron uptake, and biofilm formation, highlighting its successful spread as a pathogen in various regions and clinical settings, particularly originating from Thailand.
View Article and Find Full Text PDF

Background: The genus is increasingly implicated in human infections, but knowledge of its clinical characteristics and antimicrobial resistance profiles has been limited owing to its complex taxonomy.

Methods: We conducted a multicenter prospective cohort study of patients with infections at hospitals across Japan. Patients were eligible for inclusion if they had an spp.

View Article and Find Full Text PDF

Extended Spectrum Beta Lactamases (ESBLs) are the most prevalent enzymes conferring resistance to beta-lactams encoded on plasmids and rarely in chromosomes. This genomic study aims to characterize Escherichia coli to identify antimicrobial resistance genes (ARG), virulence factors, and phylogenetic relationships among ESBL-positive and negative isolates of E. coli obtained from Al-Kharj, Riyadh region, Saudi Arabia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!